Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: How can we differentiate?

Turkish Journal of Gastroenterology

Volumn 15, Issue 3, 2004, Pages 123-125

  Kaymakoǧlu, Sabahattin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BENZARONE; CLOMETACIN; DICLOFENAC; DYDROGESTERONE; ETRETINATE; FENOFIBRATE; HALOTHANE; LISINOPRIL; METHYLDOPA; MINOCYCLINE; NITROFURANTOIN; OXYPHENISATINE; PAPAVERINE; PROPYLTHIOURACIL; SULFONAMIDE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; DRUG EFFECT; EDITORIAL; FEMALE; FOLLOW UP; HEPATITIS A; HUMAN; JAUNDICE; LIVER BIOPSY; SPLENOMEGALY; SYMPTOM; TOXIC HEPATITIS;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOIMMUNITY; DYDROGESTERONE; FEMALE; HEPATITIS, AUTOIMMUNE; HEPATITIS, CHRONIC, DRUG-INDUCED; HUMANS; LIVER; PROGESTINS;

EID: 33847723589     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Altintas E, Oguz D, Kacar S, et al. Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia. Turk J Gastroenterol 2004 Mar; 15: 49-52.
2. Liu ZX, Kaplowitz N. Immune-mediated drug-induced liver disease. Clin Liver Dis 2002; 6: 467-86.
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of international concencus meeting. Int J Clin Pharmacol Ther Toxicol 1990; 28: 317-22.
4. Tai D, Changchien CS, Chen CJ, et al. Sequential evaluation of portal venous hemodynamics by Doppler ultrasound in patients with severe acute hepatitis. Am J Gastroenterol 1996; 91: 545-50.
5. Ferenci P. Review article: diagnosis and current therapy of Wilson's disease. Aliment Pharmacol Ther 2004; 19: 157-65.
6. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
7. Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004 Jul; 2(7): 625-31.
8. Kaymakoglu S, Cakaloglu Y, Demir K, et al. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 1998; 28: 78-83.
9. Lohse AW, Kogel M, Meyer zum Buschenfelde KH. Evidence for spontaneous immunosuppression in autoimmune hepatitis. Hepatology 1995; 22: 381-8.
10. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
11. Urganci N, Akyildiz B, Yildirmak Y, et al. A case of autoimmune hepatitis and autoimmune hemolytic anemia following hepatitis A infection. Turk J Gastroenterol 2003; 14: 204-7.
12. Zimmerman HJ, Ihsak KG. Hepatic injury due to drugs and toxins. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP (eds). Pathology of the Liver. TV. Ed. Churchill Livinstone. London. 2002; 621-709.
13. Saarni HU, Stengard J, Karki NT, et al. Medroxyprogesterone acetate improvement of the hepatic drug-metabolizing enzyme system in rats after chemical liver injury. Biochem Pharmacol 1983; 32: 1075-81.